Jean Marc Bellemin Iovance Biotherapeutics, Inc. (IOVA) insider trading activity

Jean Marc Bellemin is Chief Financial Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 29,348 shares of IOVA, which is worth approximately $303,458. The most recent transaction as insider was on Sep 03, 2024, when has been sold 11,891 shares (Common Stock) at a price of $10.85 per share, resulting in proceeds of $129,017. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.3K

64.87% 3M change

64.87% 12M change

Total Value Held $303,458

Jean-Marc Bellemin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Payment of exercise price or tax liability	$129,017 $10.85 p/Share	11,891 Reduced 28.83%	29,348 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	23,438 Added 36.24%	41,239 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$64,478 $6.11 p/Share	10,553 Reduced 37.22%	17,801 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	-	18,850 Added 39.93%	28,354 Common Stock
Jun 14 2022	SELL Payment of exercise price or tax liability	$72,245 $7.73 p/Share	9,346 Reduced 49.58%	9,504 Common Stock
Jun 14 2022	BUY Exercise of conversion of derivative security	-	18,850 Added 50.0%	18,850 Common Stock

Jean Marc Bellemin

Chief Financial Officer

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Value

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA

Account